Earlier this year, the company has introduced Astral ventilators in the European and selected Asia-Pacific markets.

The Astral 100 features single valve circuit system with one integrated QuickConnect tube and leak circuit options, as well as easy-to-read touchscreen display with real-time pressure and flow data for a comprehensive picture of a patient’s condition.

The Astral 150 features double-circuit system, which measures patient’s exhaled breath in real time. It also monitors the percentage of enriched oxygen used by a patient.

ResMed respiratory care strategic business unit president Geoff Neilson said the new Astral platform reflects firm’s longstanding history of patient-centric design and innovation.

"Astral has been well-received in Europe and Asia-Pacific, and we’re looking forward to U.S. patients enjoying more freedom and mobility, with an easier transition from hospital to home," Neilson added.

Image: ResMed has launched Astral life support ventilators in US. Photo: courtesy of PRNewsFoto/ResMed Inc.